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a b s t r a c t 
Incisional hernia is a frequent complication of midline laparotomy and enterostomal creation and is as- 
sociated with high morbidity, decreased quality of life, and high costs. The International Symposium on 
Incisional Hernia Prevention was held October 19 –20, 2017, at the InterContinental Hotel in San Fran- 
cisco, CA, hosted by the Department of Surgery, University of California, San Francisco. One hundred and 
three attendees included general and plastic surgeons from 9 countries, including principal participants 
for several of the seminal studies in the field. Over the course of the 2-day meeting, there were 38 oral 
presentations, 3 keynote lectures, and 2 panel discussions. The Symposium was a combination of new 
information but also a comprehensive review of the existing data so as to assess the current state of the 
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field and to set the stage for future research. Further, the Symposium sought to increase awareness and 
thus emphasize the importance of preventing the formation of incisional and enterostomal hernias. 
© 2018 Elsevier Inc. All rights reserved. 
Epidemiology, pathogenesis & economics of incisional hernias 
Although the overall epidemiology of incisional hernias has 
been well delineated, the fundamental pathogenesis of this post- 
operative complication and how to identify patients at increased 
risk remain topics of active interest and research. Furthermore, the 
substantial economic impact of the condition, estimated to be > $3 
billion annually in the US, is garnering more attention. 
A systematic review of factors affecting midline incisional hernia rates 
A comprehensive review of the literature, including the largest 
meta-regression analysis published to date on the subject, identi- 
fied several factors that independently increased the risk of mid- 
line incisional hernia. The factors included increasing age, obe- 
sity (or upper midline incision alone), abdominal aortic aneurysm 
surgery, previous laparotomy, and previous incisional hernia re- 
pair. 1 Notably, there was no evidence that suture type (absorbable 
vs nonabsorbable) affects the rate of hernia formation. The over- 
all pooled incidence of incisional hernias of midline wounds at 2 
years was 12.8% with a wide range (0% –36%). 
Incisional hernias represent a failure of early wound healing 
Whereas most incisional hernias are not clinically apparent 
for 12 –18 months after abdominal surgery, compelling evidence 
from a few studies indicates that the hernias develop within a 
few weeks after surgery due to a failure of early wound heal- 
ing. Normal wound healing involves an orderly sequence of well- 
coordinated interactions between various forms of cells in the in- 
flammatory response and the extracellular matrix consisting of 4 
phases: coagulation, inflammation, proliferation, and remodeling. 
Collagen deposition and maturation occurs during the prolifera- 
tion and remodeling phases, respectively, with a progressive in- 
crease in the ratio of collagen type 1:type 3 signifying a more 
organized extracellular matrix. In most causes of deficient early 
wound healing, such as seen in diabetic patients, recent evidence 
implicates altered inflammation due to the decreased recruitment 
of bone-marrow-derived circulating cells. 2 Clinical evidence that 
failed early wound healing causes incisional hernias includes stud- 
ies wherein metallic clips placed as markers of the opposed fas- 
cial edges were shown to have separated > 1 cm within 30 days 
after operation in patients who went on to develop incisional her- 
nias. 3 The radiographic detection of separation of these metal clips 
in the early phase of wound healing after operation was both 
sensitive and specific for the eventual formation of an incisional 
hernia. A close association of fascial separation detected by com- 
puted tomography (CT) within 1 month after laparotomy with later 
formation of ventral hernias provided further evidence that inci- 
sional hernia formation represents a failure of early wound heal- 
ing. 4 The forces on the abdominal wall are greater than the sum of 
the strength of biologic healing and the physical construct of the 
repair, leading frequently to failure at the suture-tissue interface 
with suture pull-through. Therefore, the prevention of incisional 
hernias should target methods that support the early inflammatory 
phase of wound healing. 
Economic perspectives on incisional hernia prevention 
Hernia prevention can come in many forms, including de- 
creased infection, less open surgery, patient “prehabilitation,” op- 
timal suture technique, and mesh-reinforced closures. Prehabilita- 
tion relevant to preventing incisional hernias would include steps 
taken to optimize a patient’s wound healing, including control of 
diabetes, smoking cessation, weight loss, and good overall nutri- 
tional status. Several key stakeholders have been identified, in- 
cluding patients, hospitals, payers, industry, and providers. Anal- 
ysis of the nationwide inpatient sample demonstrates that ap- 
proximately 1.9 million patients underwent open surgery in 2013, 
and this population exhibited a relevant and substantial comorbid- 
ity burden as evidenced by the high prevalence of obesity, pul- 
monary disease, and diabetes. Based on a simple calculation, ap- 
proximately 60 0,0 0 0 patients per year undergoing open surgery 
are at a markedly increased risk for developing an incisional her- 
nia. Recent work has demonstrated the cost utility of the mesh- 
reinforced closure, establishing that adding mesh to abdominal 
wound closure to prevent hernia could add benefit to society and 
decrease overall costs. 5 This work has also been validated as it re- 
lates to the payers’ perspective. From the hospitals’ perspective, 
strong consideration is paid toward the cost of an effective pre- 
ventative technique and its impact on Medicare Severity Diagnosis 
Related Group payments. Currently, there is a category III CPT code 
(0437T) available for use, with current efforts under way to con- 
vert this research code to a reimbursable, category I code in the 
near future. 
Suture closure of the abdomen 
Nonclinical data published in 2001 6 heralded the increased 
bursting strength of an abdominal incision when small (3 –6 mm) 
bites of the fascia were taken as compared to 1-cm bites. Over 15 
years later, the body of clinical data demonstrating a decrease in 
rate of incisional hernia formation when laparotomies are closed 
using the small bites technique continues to grow. Yet, widespread 
adoption remains a challenge. In addition, other suturing methods 
and suture types are under investigation. 
Small bites versus large bites: The STITCH Trial 
In 1993, Israelsson and Jonsson published a landmark, prospec- 
tive clinical study introducing the importance of a suture length 
to wound length ratio of > 4 in preventing incisional hernias af- 
ter midline laparotomy. 7 Subsequent studies have corroborated 
this seminal observation. Most recently, a prospective, multicen- 
ter, double-blind, randomized controlled trial (RCT) was conducted 
in surgical and gynecologic departments in 10 hospitals located 
throughout the Netherlands comparing the traditional, large bites 
suture technique with the small bites technique for fascial closure 
of midline laparotomy incisions. 8 Adult patients were equally as- 
signed to closure of the incision using large bites (1-cm bites ev- 
ery 1 cm) versus small bites (5-mm bites every 5 mm). The pri- 
mary outcome was the occurrence of incisional hernia; the hypoth- 
esis was that the incidence would be less in the small bites group. 
Over approximately 29 months, 560 patients were randomized to 
the large bites group (n = 284) or the small bites group (n = 276). 
Patients in the small bites group had fascial closures sutured with 
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more stitches than those in the large bites group (mean ± SD num- 
ber of stitches 45 ±12 vs 25 ±10; P < .0 0 01), a greater ratio of su- 
ture length to wound length (5.0 ±1 • 5 vs 4.3 ±1 • 4; P < .0 0 01), and a 
greater closure time (14 ±6 min vs 10 ±4 min; P < .0 0 01). The rates 
of adverse events did not differ significantly between groups. There 
were significantly more incisional hernias in the large bites group 
(21% vs 13%; P = .022, covariate adjusted odds ratio 0.52, 95% con- 
fidence interval 0.31 –0.87; P = .0131) at 1-year follow-up. These 
findings indicate that the small bites suture technique is more ef- 
fective than the traditional large bites technique for prevention of 
incisional hernia in midline incisions and is not associated with 
a greater rate of adverse events. This study provides further evi- 
dence that the small bites technique should become the standard 
technique for closing midline incisions. 
Hughes abdominal repair (HART) trial 
The “Hughes repair,” also known as the “Cardiff repair,” is a 
standard mass closure combined with a series of horizontal and 
2 vertical mattress sutures within a continuous suture. The closure 
technique is thought to distribute the load both along and across 
the incision length and thus, theoretically, avoids ischemia and su- 
ture pull-through. Although there is evidence that the technique 
is as effective as mesh for repairing incisional hernias, 9,10 no tri- 
als have compared the Hughes repair to the standard mass closure 
for preventing incisional hernias after a midline incision. The HART 
Trial is a prospective, randomized controlled trial at 28 centers 
throughout the United Kingdom that will compare the “Hughes 
closure” to the surgeons’ customary suture techniques. 11 The inves- 
tigators have almost finished recruiting the planned 800 patients, 
which includes those with colorectal cancer undergoing a midline 
incision of more than 5 cm and both emergency and elective pa- 
tients. Results are expected to be reported within the next 2 years. 
Of note, all published randomized clinical trials and meta- 
analyses indicate that the best way to decrease the risk of inci- 
sional hernia when closing the abdominal wall with suture after 
elective, midline laparotomy is a small bites, continuous technique 
using slowly absorbable, monofilament suture, eg, 2-0 polydiox- 
anone or polyglyconate. This technique has been shown repeatedly 
to yield a suture length:wound length ratio of ≥4. Consequently, 
this method should become the standard closure technique for 
midline incisions. Notably, there is little evidence on how to best 
close the abdomen after emergency surgery, in morbidly obese pa- 
tients, or when using other types of abdominal incisions. 
Prophylactic mesh augmentation: Laparotomies 
Another strategy to decrease the incidence of incisional her- 
nias involves prophylactic reinforcement of the fascial closure with 
prosthetic mesh, especially in patients at increased risk for this 
complication. Early reports on the use of mesh to prevent inci- 
sional hernias after weight-loss surgery date back over 2 decades 
and were initially disappointing 12 ; however, substituting prosthet- 
ics made from permanent rather than absorbable materials has 
yielded considerably better results. The current challenges include 
where best to position the mesh and how to more accurately iden- 
tify high-risk patients who stand to most benefit from this inter- 
vention. 
Onlay mesh reinforcement after midline and subcostal incisions 
Incisional hernias are a problem for all patients undergoing 
abdominal surgery, including gastrointestinal, vascular, urologic, 
and gynecologic procedures. Recently, investigators reported hernia 
rates of 30%, 53%, and 56% in urologic, gynecologic, colorectal, and 
all other patients with cancer undergoing abdominal surgery. 13 Im- 
portantly, an expanding body of evidence demonstrates the safety 
and efficacy of prosthetic mesh when placed in an onlay position 
to prevent the development of an incisional hernia. Results of a 
recent review of 172 patients in whom a prophylactic, lightweight 
polypropylene mesh was placed during the index operation yielded 
an incisional hernia rate of 7.6% with a mean follow-up of 5 
years (unpublished). Although 2 of the 172 patients needed their 
mesh prosthetic explanted, there were no chronic seromas, no for- 
eign body reactions, and no complaints of chronic pain. Similarly, 
the use of prophylactic mesh augmentation to prevent incisional 
hernias after bilateral subcostal incisions has been reported in a 
case-control study using a lightweight, macroporous, self-gripping 
polypropylene mesh placed in a retromuscular position. 14 Both 
groups had comparable rates of local and systemic complications, 
but the incisional hernia rate was markedly less in the mesh group 
than in the historical control group (1.7% vs 17.5%; P = .0 0 06) with 
a mean follow-up of 2 years. 
Mesh augmentation after emergency surgery 
Whereas prophylactic mesh augmentation appears safe and ef- 
fective in preventing incisional hernias after elective abdominal 
surgery, there is scant data regarding this approach under emer- 
gency surgical conditions. However, Argudo et al hypothesized that 
prophylactic mesh could be used to prevent incisional hernias 
in patients undergoing emergency abdominal surgery without in- 
creased postoperative complications. 15 Accordingly, they compared 
patients retrospectively whose incisions were closed with a run- 
ning, slowly absorbable suture ( n = 190) versus those ( n = 76) with 
the addition of a partially absorbable lightweight mesh (Ultrapro; 
Ethicon, Inc, Somerville, NJ) placed in an onlay position. Median 
follow-up was 16.7 months. Addition of the mesh onlay decreased 
the incisional hernia rate by > 80% (5.9% vs 33.3%; P = .0 0 01) with- 
out an impact on surgical site infections or mortality. Thus, albeit a 
retrospective study with all it limitations in patient comparability, 
these data suggest that the use of prophylactic mesh augmenta- 
tion in emergency laparotomy effectively prevents incisional her- 
nias without increasing the procedure’s overall morbidity, even in 
the presence of wound contamination. 
PRImary Mesh Closure of Abdominal Midline Wound (PRIMA) trial: 
Prevention of incisional hernia with mesh augmentation in midline 
laparotomies 
The PRImary Mesh Closure of Abdominal Midline Wound trial 
was a multicenter, double-blind RCT involving high-risk patients 
with either an abdominal aortic aneurysm or a BMI ≥27 who were 
undergoing an elective midline laparotomy. 16 The trial investigated 
both the benefit of augmentation with prophylactic mesh and the 
best location for placing the mesh. Specifically, patients were as- 
signed randomly to primary suture closure, onlay mesh augmen- 
tation, or sublay (retrorectus) mesh augmentation. The primary 
endpoint of the study was the incidence of incisional hernia at 2 
years. Whereas both mesh augmentation techniques significantly 
decreased the rate of incisional hernia formation compared to pri- 
mary suture closure (13% or 18% vs 30% ; P ≤ .05), the proportion 
of patients with an incisional hernia was not different between the 
mesh augmentation groups. Onlay mesh augmentation was asso- 
ciated with more frequent seromas (18%) than in the suture clo- 
sure or sublay mesh groups but without an increase in surgical site 
infections, reinterventions, or hospital readmissions. In conclusion, 
prevention of incisional hernias was achieved with both onlay and 
sublay mesh augmentation, supporting the use of this approach as 
a standard treatment in high-risk patients. 
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PREventive midline laparotomy closure with a BIOabsorbable mesh 
(PREBIOUS) trial: Absorbable mesh augmentation 
Incisional hernia after midline laparotomy is a complication de- 
tectable within the first 30 days after abdominal surgery. Sev- 
eral different methods for selectively reinforcing the incised linea 
alba have been described. The PREBIOUS (PREventive midline la- 
parotomy closure with a BIOabsorbable mesh) trial is an active, 
randomized, control trial examining the potentially beneficial ef- 
fects of reinforcing a midline laparotomy incision with a bioab- 
sorbable (GORE BIO-A; W. L. Gore & Associates, Inc, Flagstaff, AZ) 
prosthetic. 17 The prophylactic strategy of inserting a bioabsorbable 
prosthetic between the healing edges of the midline fascia has 
been successfully demonstrated in a preclinical study in rodents. 18 
At present, the PREBIOUS trial has recruited approximately 250 pa- 
tients undergoing both elective and emergency abdominal surgery. 
No comparative data is yet available. As expected, however, ap- 
proximately 30% of patients who have completed the planned 2- 
year follow-up period have developed an incisional hernia. We 
await the results of this interesting approach toward prevention of 
incisional hernias. 
Prophylactic onlay mesh implantation after abdominal aortic 
aneurysm repair: 2-year results 
The incidence of incisional hernias after an open repair of an 
abdominal aortic aneurysm through a midline approach has been 
reported to be as high as 38% at 2 years of follow-up and 69% 
at 5 years. In 2016, a multicenter, RCT demonstrated that prophy- 
lactic mesh augmentation prevents incisional hernias after the re- 
pair of aortic aneurysms via a midline laparotomy. 19 The Amster- 
dam Investigator-initiateD Absorb Strategy All-comers (AIDA) trial, 
also a multicenter RCT, examined the hypothesis that a lightweight, 
large-pore polypropylene mesh onlay would decrease incisional 
hernia formation compared to suture closure alone using 1 of 2 
different types of suture. A total of 108 patients (mean age 69.8 ±
7.7 years) were randomized between February 2011 and July 2013. 
After 24 months, the mesh onlay decreased the rate of incisional 
hernias by 5-fold and 8-fold, respectively (onlay mesh: 4.1 % vs 
suture A: 23.1% or suture B: 31.8%; P = .026). After 24 months, 
the number of hernias was decreased after prophylactic mesh on- 
lay compared to a running line suture closure ( P = .026). There was 
a significant difference in wound seromas, which were exclusively 
found in the mesh-treated patients (18%), but there were no sig- 
nificant differences in pain measured by the Visual Analog Scale 
or quality of life measured by the EQ-5D questionnaire between 
the groups. Consequently, the investigators concluded that onlay 
mesh after median laparotomy for repair of an abdominal aortic 
aneurysm decreased the rate of incisional hernias. 
Prevention of parastomal hernias 
Parastomal hernias are a common, frequently debilitating condi- 
tion that affects an estimated 50% to 80% of patients with a stoma, 
depending on the sensitivity of the diagnostic method. 20 Further- 
more, operative repair can be difficult, with recurrence rates of up 
to 17%, even when prosthetic mesh is used to reinforce the sur- 
rounding abdominal wall. 21 Recently, as more effective treatments 
have increased the survival of colorectal cancer patients, more at- 
tention has been focused on dysfunctional stomas and their impact 
on patient overall quality of life. In 2004, Israelsson et al published 
the results of a randomized trial demonstrating that placement of 
mesh prophylactically at the time of creation of the stoma signif- 
icantly and markedly decreased the formation of parastomal her- 
nias without leading to infective complications. 22 Yet, despite pos- 
itive RCTs, conclusive meta-analyses, and a strong recommendation 
from the European Hernia Society, fear of mesh-related complica- 
tions and some contradictory reports prevent many surgeons from 
prophylactically reinforcing the stoma site with mesh to prevent 
parastomal hernias. 23,24 
GRECCAR 7: A study in primary prevention of parastomal hernias 
GRECCAR 7, a multicenter, randomized trial involving 199 pa- 
tients, was designed to determine whether insertion of a prophy- 
lactic mesh at the time of creation of a colostomy would de- 
crease the incidence of formation of a parastomal hernia. During 
the Symposium, one of the investigators presented that there was 
no statistical difference in pain, healing of the stoma, quality of life 
(Stoma-QOL test), or frequency of stomal complications between 
the intervention group and the control group after 3 months of 
follow-up. The early data indicate that inserting a synthetic mesh 
when creating an end colostomy via an open or laparoscopic ap- 
proach is a safe and easy procedure. We await the results of long- 
term follow-up to determine the impact of mesh placement on for- 
mation of a parastomal hernia. 
PREVENT-trial for prevention of parastomal hernias 
The PREVENTion of parastomal hernia trial is an RCT that exam- 
ined whether the use of a lightweight polypropylene mesh placed 
in a sublay (retromuscular) location decreased the incidence of 
parastomal hernia as compared to the conventional method of 
creating an end colostomy. The incidence of parastomal hernia, 
morbidity, mortality, quality of life, pain, and cost-effectiveness 
was measured after 1 year of follow-up. Although the opera- 
tive time was 26 minutes greater, patients treated with mesh 
had no infections, strictures, fistulas, or cases where the mesh 
needed to be removed. 25 Sublay mesh markedly decreased the 
incidence of parastomal hernias as compared to control patients 
after 1 year of follow-up (4.5% vs 24.2%; P = .0011). Interest- 
ingly, the study demonstrated no statistically significant difference 
in quality of life, pain, or cost-effectiveness. Therefore, whereas 
prophylactic mesh reinforcement during colostomy creation effec- 
tively decreased parastomal hernia formation, it had no impact on 
other important patient-centered measures, including postopera- 
tive complications, quality of life, or costs. 
Of note, data derived from meta-analyses provide compelling 
evidence in support of the PREVENT-trial and how to prevent para- 
colostomy hernia formation after open surgery, 26 but data are in- 
conclusive regarding the best method of preventing parastomal 
hernia when a laparoscopic approach is used. 27,28 
Stapled mesh reinforcement technique 
First reported in 2011, SMART (Stapled Mesh stomA Reinforce- 
ment Technique) is a novel method of constructing a reinforced, 
end ostomy. 29 In brief, the procedure begins with using a circular 
(EEA) stapler and a 7-cm circular piece of lightweight polypropy- 
lene mesh to create a 28-cm to 31-cm funnel-shaped opening in 
the posterior rectus sheath, and ends by suturing the outer border 
of the mesh circle to the anterior rectus sheath. In this manner, a 
precise, mesh-reinforced fascial opening is cut through which the 
intestine can be delivered and a stoma matured. Recent reports in- 
dicate that the SMART method for stoma creation is safe and effec- 
tive, with few wound complications and a significantly decreased 
rate of formation of parastomal hernias. 29,30 During the Sympo- 
sium, a series of 16 patients whose stomas were created via the 
SMART method between January 2015 and September 2017 in San 
Camillo Hospital, Trento, Italy was presented. The average age of 
the cohort was 71 ± 10 years, with a mean BMI = 25 ± 4, and me- 
dian follow-up was 16 ± 8 months. Notably, although there was 
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no stoma-related morbidity, there were 3 (19%) small (EHS type 
I), “clinically insignificant” parastomal hernias that developed that 
were only detected by CT; although they were “clinically insignif- 
icant,” and have not yet required reoperation, the future of these 
small hernias is as yet undetermined but concerning. 
Non-mesh techniques of stoma creation 
Mesh prophylaxis for prevention of parastomal hernias has 
been shown to be quite successful, but the adoption rate for this 
technique in the United States has been disappointingly low. Sur- 
geons and patients alike have voiced concerns regarding the place- 
ment of prosthetic material during stoma creation and the use of 
mesh in general, especially given the abundant and well-publicized 
lawsuits in America involving complications connected to these 
prosthetics. Therefore, methods of preventing parastomal hernias 
without the use of mesh are worth examining. The basic dogma 
of stoma creation includes steps that have little scientific support 
and demonstrate considerable variability in practice. These contro- 
versies include the optimal size of the ellipse of skin excised, the 
size and shape of the incision in the anterior rectus sheath (cruci- 
ate vs elliptical), the location (through vs adjacent to the rectus ab- 
dominis muscle), and an intraperitoneal versus an extraperitoneal 
pathway through the abdominal wall. Ongoing studies are exam- 
ining some of these questions, 31 and a systematic analysis identi- 
fied creation of an extraperitoneal stoma as being associated with 
a significantly lesser rate of parastomal hernia formation (18% vs 
6%). 32 
Hernia prevention: Science, education & reimbursement 
Extracellular matrix (Surgisis Gold) in hernia prevention surgery 
Early in the product life cycle of Surgisis Gold, Cook Medical 
(West Lafayette, IN) undertook a 400-patient, randomized, con- 
trolled clinical trial to determine whether an extracellular-matrix- 
based graft could dramatically decrease the rate of primary mid- 
line hernia formation in the clean-contaminated population of pa- 
tients undergoing an open Roux-en-Y gastric bypass, the results of 
which were presented during the Symposium. 33 Overall, the im- 
plant group had more adverse events than the suture-only control 
group, but the hernia rate at 2 years of follow-up was not signifi- 
cantly different. This lack of significance was attributed potentially 
to patients lost to follow-up, failures of the surgical technique, and 
the challenge of healing in this complex patient population. Inter- 
estingly, the pattern of hernia development over time appeared to 
differ between the 2 groups. Whereas early failures were more fre- 
quent in the Surgisis Gold group, failures in the suture-only group 
appeared at a more constant rate over time. Hernia prevention, as 
a treatment modality, may have very different objectives than tra- 
ditional hernia repair, but the principles of good wound healing, 
patient selection, and proper procedures for the types of implant 
likely affect the outcomes. 
Trocar hernia incidence and prophylaxis 
The incidence of hernias at the trocar site after laparoscopic op- 
erations is likely underreported. Whereas short-term, retrospective 
series note rates of 1% to 6%, greater follow-up of patients under- 
going a laparoscopic cholecystectomy has noted hernias in up to 
26% of patients at 3 years. 34 Older patients and those with a high 
BMI, an existing umbilical hernia, or superficial surgical site infec- 
tion are at greater risk for trocar site herniation. There are a num- 
ber of different trocar types, and it is unclear if the type of tro- 
car used has an impact on the rate of herniation. A 2015 Cochrane 
review included a comparative analysis of radially expanded ver- 
sus cutting trocars and reported no trocar site herniation among 
462 patients in 4 studies with follow-up of 6 –48 months 35 ; how- 
ever, this study was considered to be of low quality evidence. It 
does appear, however, that the risk of herniation increases with 
the size of the trocar used. Although the rate of herniation at 5- 
mm trocar sites appears to be very low, it is significantly greater 
for trocars with diameters larger than 10 mm, for which port site 
fascial closure is recommended. In an RCT of sutured versus pros- 
thetic mesh closure of umbilical port sites ( ≥10 mm), mesh place- 
ment dramatically decreased the rate of trocar site hernias (31.9% 
vs 4.4%; P < .001). 36 Although the advocates of robotic surgery 
tout decreased trauma at robotic port sites, the rates of port site 
hernias after robotic surgery appear statistically no different than 
that of traditional laparoscopic ports. Whereas meticulous closure 
is recommended for all port sites > 5 mm, prophylactic mesh rein- 
forcement is probably best reserved for the larger diameter trocar 
sites in high-risk patients. 
Implementing a program to improve abdominal wall closure 
During the Symposium, a program to implement the small bites 
(5-mm bites every 5 mm) technique for closing laparotomies in all 
of the surgical departments in a public, general hospital was pre- 
sented. The program consists of 3 phases: (1) Information, (2) Cer- 
tification, and (3) Audit. In the period between July 2016 and April 
2017, a total of 460 laparotomies were performed in 416 patients. 
Review of the program revealed that in only 36% of the opera- 
tions did the surgeons adhere to the complete protocol. But, after 
a 6-month follow-up period, patients whose abdominal walls were 
closed according to the complete protocol experienced a lesser 
incidence of burst abdomen and incisional hernias than patients 
where the closure protocol was incomplete. Whereas the small 
bites technique is easy to teach and learn, implementation of the 
closure method is difficult, thought to be due in part to surgeon re- 
sistance to change and the known delay getting research evidence 
into clinical practice. 37 
Predicting the risk of incisional hernia 
In considering any prophylactic intervention, it is critically im- 
portant to weigh the relative risks of the condition against those 
of the intervention. Therefore, in the case of attempts to prevent 
incisional hernia formation, preoperative risk stratification and de- 
cision algorithms will be of potentially important value. Published 
studies have identified many common preoperative risk factors, in- 
cluding obesity, open surgery, smoking, prior surgery, abdominal 
aortic aneurysm, and wound contamination as predictors of for- 
mation of incisional hernias. Recently, several investigators identi- 
fied a multitude of risk factors and created risk models for predict- 
ing incisional hernias after surgery. 5,38 An important next step will 
be to translate these risk models into practice through decision- 
support interfaces that allow real-time calculation of risk at point 
of care to further personalize an individual patient’s operative 
management. Specific interventions of preoperative and operative 
risk reduction could include weight loss, smoking cessation, im- 
proved glucose management, optimal fascial closure method, and 
prophylactic soft tissue reinforcement. 
Hernia prevention: Research & novel approaches 
The federal agenda toward research 
Complex ventral hernias can present unique clinical and tech- 
nical challenges to the health-care team. Frequently, the operating 
surgeon must innovate and craft customized solutions for a specific 
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patient under circumstances where the best repair technique or 
prosthetic device to use is uncertain. As such, what distinguishes 
innovation versus research? Innovation is a process undertaken for 
the sole benefit of a single patient. 39 When an innovative tech- 
nique is used in 3 or more patients, it becomes clinical research 
whether or not the surgeon plans to report it and as such, this in- 
novative procedure requires approval by the Institutional Review 
Board beforehand. If the surgeon reports his or her Institutional 
Review Board-approved experience with a new technique or de- 
vice, it is an anecdotal (case) report, and if the results are com- 
pared with historic controls, it is a retrospective series. Innovation 
is often a process whereby knowledge is used to create a new tech- 
nique or application that may have commercial value. Research is 
a process whereby resources (eg, money) are used to create new 
knowledge. Research and innovation are synergistic and mutually 
dependent. 
The federal government (eg, National Institutes of Health) 
provides research grants to enable clinical research that is not 
related to commercial interests. Examples of clinical research 
opportunities at the National Institute of Diabetes and Digestive 
and Kidney Diseases include the R21 (Pilot Project) grants, R01 
(single center) grants, U34/U01 (multicenter) grants, and K awards 
(career development grants) for young investigators. Examples of 
clinical research projects currently funded by the National Insti- 
tute of Diabetes and Digestive and Kidney Diseases in the areas 
of surgical research include projects on hepatic and hepatobiliary 
surgery, the treatment of acute appendicitis with antibiotics versus 
surgery, postoperative ileus, and the treatment of abdominal wall 
defects (hernias). There is currently little federally funded research 
regarding abdominal wall hernias, but resources are potentially 
available and can be allocated to the study of this clinically 
important condition through increased awareness, education, and 
well-crafted applications for funding. 
Prevention of hernia formation: Role of growth factors, and wound 
healing 
To prevent the formation of incisional hernias, many methods 
to alter the local expression of growth factors and the subsequent 
effects on wound healing have been tried. To date, however, no 
method has proven to be clinically relevant. Deficient recruitment 
of inflammatory cells from the bone marrow has been implicated 
as the common pathway for delayed and deficient wound healing 
in a variety of diseases. Specifically, recruitment of macrophages 
and differentiation from an M1 to an M2 phenotype results in 
collagen deposition during normal wound healing. In contrast, 
a deficient or delayed induction of M2 macrophages leads to 
poor healing and is likely to be associated with formation of 
incisional hernias. Maintaining a normal core body temperature 
in patients during operations leads to more collagen deposition 
and fewer surgical site infections. 40 Better nutritional support and 
control of serum glucose, and maintaining adequate blood flow 
to surgical sites, also produce better healing. But none of these 
factors have been well studied in clinical settings to prevent the 
formation of incisional hernias. Instead, methods such as closure 
with small bites of suture and placement of prosthetic mesh have 
been shown in multiple randomized clinical trials to decrease the 
risk of developing an incisional hernia. These techniques probably 
increase collagen deposition and fibrosis, thus augmenting the 
healing process. Hopefully, better understanding of the inflam- 
matory response and macrophage function in wound healing will 
lead to better methods to manipulate the healing of laparotomies 
and thus prevent incisional hernias. 
Closure of the abdominal wall with mesh-derived sutures 
A frequent observation with incisional hernias is the presence 
of suture pull-through, ie, sutures having torn through the fascia 
and soft tissue around which they were placed. When the forces 
applied to the abdominal wall closure exceed the repair strength, 
early failure and gap formation between the fascial borders occur, 
resulting later in an incisional hernia. This process implies that the 
cause of incisional hernia can include a problem with the “physics”
of the repair, in addition to a problem with the biology of wound 
healing. Dumanian created a new mesh suture that is almost 10 
times larger in diameter than a standard suture, but was designed 
to limit acute suture pull-through due to an improved distribution 
of forces at the suture-tissue interface. 41,42 Because much of the 
diameter of the mesh sutures is air between the filaments of the 
mesh, these filaments collapse at the knot to become smaller and 
more biocompatible. The walls of the suture are an open mesh 
so that tissue can grow into and surround the woven filaments 
as early as 8 days after placement. This “tissue integration” into 
the actual suture may limit or possibly eliminate chronic suture 
pull-through and hernia formation. Preclinical studies have shown 
increased resistance to suture pull-through in rat and porcine ab- 
dominal walls, dog shoulders, and human finger tendons. To use 
the concepts of force distribution in patients now, an off-label use 
of PROLENE Soft Mesh was devised. Cutting along the blue lines, 
20-mm-wide strips were fashioned from a single piece of mesh 
and used as sutures for both simple and complex abdominal wall 
defects. Forty-eight patients with some form of minimal potential 
wound contamination during repair of incisional hernias averaging 
10 cm in width were closed with this “mesh sutured repair.”43 The 
recurrence rate of hernia formation was 13% with a mean follow- 
up of 12 months. Therefore, mesh sutured repairs may represent 
a new era of high surface area/low filament size closures that dis- 
tribute forces and lay down a magnified foreign-body response at 
the site of suture closure. An FDA-cleared mesh suture product 
should be available for clinical use in 2018. 
Advances in mesh technology: T-line hernia mesh 
Mesh functions to prevent ventral hernia formation by enhanc- 
ing wound healing and distributing tension to the lateral abdom- 
inal wall. But mesh often fails at the suture-mesh-tissue inter- 
face; this failure may be because the suture “cheese wires” or 
slices through mesh or tissue because the tensile stress of the ab- 
dominal wall exceeds the tensile strength of the anchor points of 
the suture-mesh-tissue interface . To overcome this cheese wiring 
caused by tensile stress, Levinson and colleagues have developed 
a novel mesh prosthetic. The T-line hernia mesh contains seam- 
less, uninterrupted extensions continuous with the mesh body that 
are 15-fold the surface area of standard suture. The extensions are 
sewn into fascia, just as sutures would be, and the T-line hernia 
mesh remains anchored to fascia at forces 300% greater than the 
maximum force exerted on the abdominal wall (16 N/cm). By com- 
parison, the anchor points of standard suture repairs fail at 6–12 
N/cm. In bench-top studies, the T-line mesh meets all federal per- 
formance and safety standards, and in pig studies, the mesh is safe 
and 275% stronger than standard mesh. In summary, one strategy 
for decreasing the risk of hernia formation is to develop a mesh 
that overcomes tensile stress and failure of the mesh-suture-tissue 
interface. T-line mesh appears to achieve this strategy by maintain- 
ing a broader surface area of anchor point contact with the fascia 
and by distributing tension from the midline to the lateral abdom- 
inal wall. Clinical trials are planned. 
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Nanofiber electrospun technology for prevention of incisional hernias 
A device able to support and accelerate the healing of in- 
jured abdominal wall tissue postoperatively would likely decrease 
the incidence of incisional hernia formation. Currently, the pros- 
thetic materials used for soft tissue reinforcement are primarily 
polypropylene or polyesters, some with a special layer to enhance 
specific properties of the implant and suppress other disadvan- 
tageous properties. Yet, all permanent prosthetics pose a lifelong 
risk for material-related complications, including infection, seroma, 
adhesions, and pain. Electrospun nanofibers made from soluble 
polyesters are used widely as scaffolds f or tissue engineering. Their 
production is cost-effective and fast. It is possible to make fibers 
with specific mechanical properties and enrich them with con- 
trolled released of growth factors, antibiotics, or other drugs. 44 Al- 
though in vitro testing indicates excellent biocompatibility, how 
these materials perform in vivo is unknown. In an established rab- 
bit model, the nanofiber material appears to support the growth 
of fibrous tissue and mature collagen. The resulting scar is more 
elastic, contains less fat, and exhibited less shrinkage compared to 
the use of polypropylene nanofibers. Further studies are focused on 
more complete characterization of the host response to this novel 
material. 
MYOSEAL: Enhanced myofascial wound healing 
Incisional hernias, the most frequent long-term complication of 
abdominal surgery, result from inadequate early wound healing. In 
1894, Phelps reported the use of small silver coils during hernia re- 
pairs, exploiting the observation that as the implanted silver metal 
slowly disintegrated, it induced a local inflammatory response and 
wound fibrosis. 45 Despite impressive clinical results with hernia re- 
currence rates of < 0.5%, 45,46 the disuse of silver wire prosthetics 
coincided with advances in polymer chemistry that produced new 
prosthetic materials, especially polypropylene (PROLENE), which 
was viewed as a superior alternative. Recently, investigators postu- 
lated that using microparticles of silver (MYOSEAL; Vitruvian, San 
Francisco, CA, USA) rather than fine silver wire would effectively 
accentuate the therapeutic benefits of this unique prosthetic ma- 
terial, including wound fibrosis. Through extensive preclinical ex- 
periments, this fascinating property of implanted metallic silver 
has been applied in an innovative way for a novel indication. Ani- 
mal studies have demonstrated that MYOSEAL, when mixed in the 
wound with a commercial fibrin tissue sealant, enhances myofas- 
cial wound healing, resulting in decreased incisional hernia for- 
mation. Specifically, the MYOSEAL significantly decreased the in- 
cidence and size of incisional hernias in a dose-dependent and se- 
lective manner in an established rodent model. These data support 
the evaluation of silver microparticles as an innovative, safe, and 
highly feasible strategy to increase early wound healing and thus 
prevent incisional hernias in patients. Clinical studies are planned 
for 2018. 
Hernia prevention: Perspectives of the Food and Drug Administration 
The Food and Drug Administration (FDA) is currently seeking 
methods of acquiring postmarket clinical data for the purpose 
of using these data to expand indications for use of novel ap- 
plications, facilitating surgeon choices on the appropriate mesh 
for their hernia patients, improving device labeling to better 
inform surgeons and patients, and providing a stronger postmar- 
ket signal on delayed surgical device problems than is currently 
available through Medical Device Reports. The agency has recently 
issued regulatory guidance concerning the use of real-world 
evidence (RWE) ( https://www.fda.gov/downloads/medicaldevices/ 
deviceregulationandguidance/guidancedocuments/ucm513027.pdf ). 
RWE can provide a snapshot of a new device as it performs in 
the marketplace ecosystem at any time point in its total life 
cycle. The FDA is establishing the National Evaluation System 
for Health Technology (NEST), which will use data from many 
sources, thereby linking registries (domestic and global), large 
administrative databases, insurance claims, and electronic medical 
records. The clinical data generated through NEST can then be 
used to provide a more complete picture of the risks and benefits 
of any new device throughout its life cycle and may be used for 
future regulatory decisions. Implicit in the use of RWE is that 
the data must meet a reliability threshold, also discussed in the 
guidance of the Use of Real-World Evidence to Support Regulatory 
Decision-Making for Medical Devices. Whereas the FDA remains 
understandably focused on existing hernia mesh prosthetics, 
building the infrastructure necessary to use RWE and establish 
NEST may indicate the agency’s desire for a more comprehensive 
and nimble means of evaluating the performance and expanding 
the indication of medical devices, including those that will define 
the future of incisional hernia repair and prevention. 
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